Browsing by Author "Brugieres, Laurence (7005615475)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Non-Hodgkin lymphoma and pre-existing conditions: Spectrum, clinical characteristics and outcome in 213 children and adolescents(2016) ;Attarbaschi, Andishe (6602343033) ;Carraro, Elisa (55834921600) ;Abla, Oussama (6506167666) ;Barzilai-Birenboim, Shlomit (57192254129) ;Bomken, Simon (24401060100) ;Brugieres, Laurence (7005615475) ;Bubanska, Eva (6603405979) ;Burkhardt, Birgit (9248143700) ;Chiang, Alan K. S. (7101623534) ;Csoka, Monika (22034152200) ;Fedorova, Alina (8710181800) ;Jazbec, Janez (6602993382) ;Kabickova, Edita (6602305248) ;Krenova, Zdenka (6507910356) ;Lazic, Jelena (7004184322) ;Loeffen, Jan (6602979459) ;Mann, Georg (7201974435) ;Niggli, Felix (7004026312) ;Miakova, Natalia (7801571393) ;Osumi, Tomoo (55965348200) ;Ronceray, Leila (54911933000) ;Uyttebroeck, Anne (6603028229) ;Williams, Denise (7407410786) ;Woessmann, Wilhelm (56006760500) ;Wrobel, Grazyna (7003317277)Pillon, Marta (7006404245)Children and adolescents with pre-existing conditions such as DNA repair defects or other primary immunodeficiencies have an increased risk of non-Hodgkin lymphoma. However, largescale data on patients with non-Hodgkin lymphoma and their entire spectrum of pre-existing conditions are scarce. A retrospective multinational study was conducted by means of questionnaires sent out to the national study groups or centers, by the two largest consortia in childhood non-Hodgkin lymphoma, the European Intergroup for Childhood non-Hodgkin Lymphoma, and the international Berlin-Frankfurt-Münster Study Group. The study identified 213 patients with non-Hodgkin lymphoma and a pre-existing condition. Four subcategories were established: a) cancer predisposition syndromes (n=124, 58%); b) primary immunodeficiencies not further specified (n=27, 13%); c) genetic diseases with no increased cancer risk (n=40, 19%); and d) non-classifiable conditions (n=22, 10%). Seventy-nine of 124 (64%) cancer predispositions were reported in groups with more than 20 patients: ataxia telangiectasia (n=32), Nijmegen breakage syndrome (n=26), constitutional mismatch repair deficiency (n=21). For the 151 patients with a known cancer risk, 5-year event-free survival and overall survival rates were 40%±4% and 51%±4%, respectively. Five-year cumulative incidences of progression/relapse and treatment-related death as a first event were 22%±4% and 24%±4%, respectively. Ten-year incidence of second malignancy was 24%±5% and 7-year overall survival of the 21 patients with a second malignancy was 41%±11%. Patients with non-Hodgkin lymphoma and pre-existing conditions have an inferior survival rate with a large proportion of therapy-related deaths compared to patients with non-Hodgkin lymphoma and no pre-existing conditions. They may require special vigilance when receiving standard or modified/reduced-intensity chemotherapy or when undergoing allogeneic stem cell transplantation. © 2016 Ferrata Storti Foundation.
